Deerland Probiotics and Enzymes Revenue and Competitors
Estimated Revenue & Valuation
- Deerland Probiotics and Enzymes's estimated annual revenue is currently $44M per year.
- Deerland Probiotics and Enzymes's estimated revenue per employee is $297,000
Employee Data
- Deerland Probiotics and Enzymes has 148 Employees.
- Deerland Probiotics and Enzymes grew their employee count by -7% last year.
Deerland Probiotics and Enzymes's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Product Development & Procurement | Reveal Email/Phone |
2 | VP Human Resources | Reveal Email/Phone |
3 | Director Global Strategic Accounts | Reveal Email/Phone |
4 | Procurement Manager | Reveal Email/Phone |
Deerland Probiotics and Enzymes Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $44M | 148 | -7% | N/A | N/A |
#2 | $385.9M | 1021 | -2% | N/A | N/A |
What Is Deerland Probiotics and Enzymes?
Deerland Probiotics & Enzymes, based in Kennesaw, Ga., specializes in customized enzyme and probiotic-based formulations, collaborating with customers to develop innovative and often proprietary solutions. In addition to customized formulations, the company offers a line of clinically studied branded products, including the probiotic strain DE111® and novel prebiotic PreforPro®. Deerland provides regulatory support and also performs specialty contract manufacturing services, including bulk blends, liquids, hard shell capsules, and tablets; as well as bottling and labeling. To contact Deerland Probiotics & Enzymes, call 800.697.8179 or visit www.Deerland.com.
keywords:N/AN/A
Total Funding
148
Number of Employees
$44M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $33.6M | 149 | N/A | N/A |
#2 | $30.5M | 151 | 0% | N/A |
#3 | $7.5M | 158 | 5% | N/A |
#4 | $48.4M | 163 | 16% | N/A |
#5 | $38.3M | 166 | 28% | N/A |